Feasibility and Efficacy Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery
NCT: NCT06227585 · COMPLETED
広告
NCT識別子NCT06227585
ステータスCOMPLETED
開始日2023-11-29
完了2026-01-05
SponsorAlume Biosciences, Inc. (INDUSTRY)
First posted
Last updated
概要
A Part 1 Phase 2 feasibility study to characterize the feasibility of using the REVEAL 475 system by obtaining surgeon perspective on illumination and ease of use. A Part 2 Phase 3 safety and efficacy study to evaluate conspicuity of the identified nerve due to bevonescein through the use of the Visualization Scoring System (VSS).
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。